NVO Novo Nordisk A/S Stock Quote

NVO [NYSE]

Healthcare | Drug Manufacturers - General | Denmark

Index	-	P/E	23.60	EPS (ttm)	2.95	Insider Own	26.40%	Shs Outstand	2.30B	Perf Week	-2.30%
Market Cap	128.37B	Forward P/E	20.49	EPS next Y	3.40	Insider Trans	0.00%	Shs Float	1.26B	Perf Month	-3.87%
Income	6.90B	PEG	18.02	EPS next Q	0.84	Inst Own	7.70%	Short Float	0.34%	Perf Quarter	2.16%
Sales	20.78B	P/S	6.18	EPS this Y	10.00%	Inst Trans	-2.03%	Short Ratio	4.00	Perf Half Y	5.12%
Book/sh	4.51	P/B	15.43	EPS next Y	10.36%	ROA	30.80%	Target Price	80.58	Perf Year	10.58%
Cash/sh	1.13	P/C	61.46	EPS next 5Y	1.31%	ROE	71.00%	52W Range	49.24 - 75.86	Perf YTD	-0.34%
Dividend	1.90	P/FCF	30.15	EPS past 5Y	5.90%	ROI	58.50%	52W High	-8.24%	Beta	0.45
Dividend %	2.73%	Quick Ratio	0.70	Sales past 5Y	3.30%	Gross Margin	83.50%	52W Low	41.37%	ATR	1.52
Employees	44723	Current Ratio	0.90	Sales Q/Q	-0.90%	Oper. Margin	42.60%	RSI (14)	40.63	Volatility	1.78% 1.45%
Optionable	Yes	Debt/Eq	0.16	EPS Q/Q	8.60%	Profit Margin	33.20%	Rel Volume	1.21	Prev Close	69.22
Shortable	Yes	LT Debt/Eq	0.05	Earnings	Feb 03 BMO	Payout	281.90%	Avg Volume	1.09M	Price	69.61
Recom	3.00	SMA20	-4.14%	SMA50	-2.80%	SMA200	1.83%	Volume	1,322,088	Change	0.56%

Jan-20-21

Downgrade

Credit Suisse

Outperform → Neutral

Jan-15-21

Initiated

Deutsche Bank

Buy

Sep-29-20

Initiated

Berenberg

Hold

Jul-06-20

Downgrade

BofA Securities

Buy → Neutral

May-11-20

Downgrade

UBS

Buy → Neutral

May-04-20

Initiated

Cowen

Market Perform

$72

Mar-16-20

Upgrade

BofA/Merrill

Neutral → Buy

Jan-03-20

Downgrade

Guggenheim

Buy → Neutral

Nov-18-19

Upgrade

Barclays

Equal Weight → Overweight

Sep-17-19

Upgrade

Citigroup

Neutral → Buy

Aug-30-19

Downgrade

Jefferies

Hold → Underperform

Jun-20-19

Downgrade

Deutsche Bank

Buy → Hold

Jun-11-19

Upgrade

Barclays

Underweight → Equal Weight

Apr-29-19

Upgrade

Credit Suisse

Neutral → Outperform

Jan-29-19

Initiated

Exane BNP Paribas

Outperform

Dec-11-18

Resumed

Jefferies

Hold

Oct-09-18

Initiated

Guggenheim

Buy

Dec-29-17

Upgrade

JP Morgan

Underweight → Neutral

Dec-06-17

Upgrade

BofA/Merrill

Neutral → Buy

Dec-01-17

Upgrade

Morgan Stanley

Equal-Weight → Overweight

Mar-01-21 08:53AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Feb-24-21 09:31AM	Top 15 Pharmaceutical Companies With Highest R&D Spending Insider Monkey
Feb-23-21 02:02AM	Notice for the Annual General Meeting of Novo Nordisk A/S GlobeNewswire
Feb-22-21 08:24AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Feb-17-21 03:36AM	Trading in Novo Nordisk shares by board members, executives and associated persons on 15 February 2021 GlobeNewswire
Feb-16-21 10:13AM	Trading in Novo Nordisk shares by board members, executives and associated persons on 15 February 2021 GlobeNewswire
Feb-15-21 10:13AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Feb-12-21 10:08AM	Trading in Novo Nordisk shares by board members, executives and associated persons on 11-12 February 2021 GlobeNewswire
Feb-11-21 05:58AM	Diabetes drug hailed as a breakthrough for weight loss MarketWatch
Feb-10-21 11:16AM	Trading in Novo Nordisk shares by board members, executives and associated persons on 8 February 2021 GlobeNewswire
10:28AM	Novo Nordisk CEO on 7% sales growth in 2020, healthcare outlook Yahoo Finance Video
Feb-08-21 09:29AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Feb-05-21 10:08AM	Trading in Novo Nordisk shares by board members, executives and associated persons on 3-4 February 2021 GlobeNewswire
Feb-03-21 07:00PM	Novo Nordisk A/S (NVO) Q4 2020 Earnings Call Transcript Motley Fool
10:45AM	Novo Nordisk A/S to Host Earnings Call ACCESSWIRE
08:56AM	Novo Nordisk's (NVO) Q4 Earnings and Sales Beat Estimates Zacks
08:37AM	Novo Nordisk: Q4 Earnings Insights Benzinga
04:24AM	Diabetes drugmaker Novo Nordisk upbeat on 2021, sees Biden boost Reuters
01:30AM	Novo Nordisk's net profit increased by 8% in 2020 GlobeNewswire
Feb-02-21 09:19AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jan-31-21 10:05PM	14 Best European Dividend Stocks to Buy Now Insider Monkey
Jan-28-21 09:55AM	The Zacks Analyst Blog Highlights: Facebook, Novo Nordisk, SAP, Royal Dutch Shell and American Express Zacks
Jan-27-21 02:18PM	Top Research Reports for Facebook, Novo Nordisk & SAP Zacks
Jan-25-21 08:42AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jan-21-21 12:16PM	Novo Nordisk (NVO) Files for Ozempic's Label Expansion in US Zacks
Jan-20-21 10:08AM	Novo Nordisk files for regulatory approval in the US of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes GlobeNewswire
Jan-18-21 04:25AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jan-11-21 07:14AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Jan-04-21 09:14AM	Novo Nordisk extends COVID-19 Patient Assistance Program, encourages people facing affordability challenges to visit NovoCare.com PR Newswire
Dec-30-20 11:25AM	Novo Nordisk (NVO) Files for Ozempic's Label Expansion in EU Zacks
Dec-29-20 06:12AM	Novo Nordisk files for EU regulatory approval of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes GlobeNewswire
Dec-22-20 05:32AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Dec-21-20 10:13AM	Novo Nordisk (NVO) Files for Semaglutide Label Expansion in EU Zacks
Dec-19-20 10:10PM	Is NVO A Good Stock To Buy? Insider Monkey
Dec-18-20 02:10AM	Novo Nordisk files for EU regulatory approval of once-weekly semaglutide 2.4 mg for weight management GlobeNewswire
Dec-16-20 08:08AM	Novo Nordisk to enter phase 3 development in Alzheimers disease with oral semaglutide GlobeNewswire
Dec-14-20 11:08AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Dec-09-20 12:15PM	The Zacks Analyst Blog Highlights: Alibaba, QUALCOMM, Novo Nordisk, Boeing and Delta Air Lines Zacks
Dec-08-20 04:05PM	Novo Nordisk Completes Acquisition of Emisphere Technologies for $1.35 Billion GlobeNewswire
01:22PM	Top Research Reports for Alibaba, QUALCOMM & Novo Nordisk Zacks
06:30AM	How You Can Profit From the Best-Managed Drugmaker on Earth Motley Fool
Dec-07-20 09:27AM	FDA Approves Label Expansion of Novo Nordisk's (NVO) Saxenda Zacks
09:27AM	FDA Approves Label Expannsion of Novo Nordisk's (NVO) Saxenda Zacks
09:11AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
09:04AM	Novo Nordisk A/S: Rectification GlobeNewswire
Dec-04-20 09:33PM	FDA approves Saxenda® for the treatment of obesity in adolescents aged 12-17 PR Newswire
07:29AM	Novo Nordisk files for US FDA regulatory approval of once-weekly semaglutide 2.4 mg for weight management GlobeNewswire
Nov-30-20 08:48AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Nov-25-20 09:35AM	Is Novo Nordisk (NVO) a Suitable Stock for Value Investors? Zacks
Nov-23-20 12:56PM	Novo Nordisk And Lego Board Member Joins Data-Focused Wellness Company Bellabeat Benzinga
08:36AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Nov-20-20 08:42AM	20 Largest European Companies By Market Cap in 2020 Insider Monkey
Nov-18-20 11:24AM	Novo Nordisk's (NVO) Phase IIIb Study Meets Primary Endpoint Zacks
01:29AM	15 Largest Biotech Companies in the World Insider Monkey
Nov-17-20 09:24AM	Once-weekly semaglutide 2.0 mg demonstrates superior reduction in HbA1c vs once-weekly semaglutide 1.0 mg in people with type 2 diabetes in the SUSTAIN FORTE trial GlobeNewswire
Nov-16-20 01:54PM	15 Largest Drug Companies in the World Insider Monkey
01:31PM	Gilead (GILD), Novo Nordisk Post Upbeat Data From NASH Study Zacks
09:49AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Nov-12-20 12:33PM	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Emisphere Technologies, Inc. Buyout GlobeNewswire
09:07AM	The Zacks Analyst Blog Highlights: Facebook, Verizon, Toyota Motor, Novo Nordisk, Applied Materials and General Motors Zacks
Nov-11-20 12:56PM	Top Research Reports for Facebook, Verizon & Toyota Motor Zacks
Nov-09-20 06:18PM	Emisphere Technologies, Inc. (OTC:EMIS) INVESTOR NOTICE: Abraham, Fruchter & Twersky, LLP Is Investigating the Sale of Emisphere and Encourages Investors to Contact the Firm GlobeNewswire
01:46PM	EMISPHERE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of EMIS and Encourages Investors to Contact the Firm GlobeNewswire
06:50AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
06:20AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
Nov-06-20 04:38PM	Novo Nordisk, Trading Near Highs, Announces $1.8 Billion Acquisition Investor's Business Daily
09:26AM	Trading in Novo Nordisk shares by board members, executives and associated persons on 4 and 5 November 2020 GlobeNewswire
09:09AM	(EMIS) Alert: Johnson Fistel Investigates Proposed Sale of Emisphere; Are Shareholders Getting a Fair Deal? PR Newswire
02:30AM	Novo Nordisk to boost pill-form diabetic drugs with $1.8 billion deal Reuters
Nov-05-20 09:00AM	Novo Nordisk (NVO) Catches Eye: Stock Jumps 7.2% Zacks
03:56AM	Trading in Novo Nordisk shares by board members, executives and associated persons on 4 November 2020 GlobeNewswire
Nov-03-20 02:59PM	Trading in Novo Nordisk shares by board members, executives and associated persons on 3 November 2020 GlobeNewswire
02:55PM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
02:49PM	Novo Nordisk A/S purchases B shares worth DKK 2,913 million from Novo Holdings A/S under the 2020 share repurchase programme GlobeNewswire
Oct-30-20 07:01PM	Novo Nordisk A/S (NVO) Q3 2020 Earnings Call Transcript Motley Fool
10:54AM	Novo Nordisk's (NVO) Q3 Earnings Beat Estimates, Sales Miss Zacks
02:30AM	Novo Nordisk's operating profit increased by 6% in Danish kroner and by 7% at constant exchange rates (CER) in the first nine months of 2020 GlobeNewswire
Oct-29-20 06:01AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Oct-26-20 08:47AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Oct-19-20 06:50PM	4 Health Care Companies With Strong Business Quality GuruFocus.com
11:40AM	SNY or NVO: Which Is the Better Value Stock Right Now? Zacks
07:24AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Oct-13-20 03:31PM	Q3 Earnings Scorecard and Top Research Reports for Apple, PepsiCo & McDonald's Zacks
Oct-12-20 04:14AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Oct-11-20 01:52PM	IPO Outlook: Solar Power Company Array Technologies, Chinese Retailer Miniso Lead Possible 9 IPO Week Benzinga
Oct-09-20 01:41PM	Pharma Stock Roundup: LLY, AZN, PFE, GSK Progress on Coronavirus Programs Zacks
12:30PM	Novo Nordisk Raises Sales & Operating Profit Outlook for 2020 Zacks
03:04AM	European stocks rise on upbeat forecasts from Pandora, Novo Nordisk Reuters
Oct-08-20 12:40PM	Novo Nordisk raises sales and operating profit outlook for 2020 GlobeNewswire
Oct-05-20 08:35AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Sep-29-20 06:47PM	5 Health Care Stocks Outperforming the S&P 500 GuruFocus.com
08:44AM	Novo Nordisk A/S (NVO): Hedge Funds In Wait-and-See Mode Insider Monkey
Sep-28-20 08:20AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
03:02AM	Stocks Jump, Trump's Tax and Uber Licenses: What's up in Markets on Monday Investing.com
Sep-24-20 04:30AM	Worlds largest study of cardiovascular disease in type 2 diabetes shows need for improved knowledge and disease management GlobeNewswire
Sep-22-20 08:46AM	Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial GlobeNewswire
Sep-21-20 02:03PM	The Zacks Analyst Blog Highlights: JPM, PYPL, NVO, RHHBY and TM Zacks
10:13AM	Novo Nordisk A/S Share repurchase programme GlobeNewswire
Sep-18-20 03:14PM	Top Analyst Reports for JPMorgan, PayPal & Novo Nordisk Zacks
11:40AM	SNY vs. NVO: Which Stock Should Value Investors Buy Now? Zacks

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience